These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 27857809)

  • 21. Sanfilippo type B syndrome (mucopolysaccharidosis III B): allelic heterogeneity corresponds to the wide spectrum of clinical phenotypes.
    Weber B; Guo XH; Kleijer WJ; van de Kamp JJ; Poorthuis BJ; Hopwood JJ
    Eur J Hum Genet; 1999 Jan; 7(1):34-44. PubMed ID: 10094189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of motor deficits in a murine model of mucopolysaccharidosis type IIIA (MPS-IIIA).
    Hemsley KM; Hopwood JJ
    Behav Brain Res; 2005 Mar; 158(2):191-9. PubMed ID: 15698885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous delivery of a chemically modified sulfamidase efficiently reduces heparan sulfate storage and brain pathology in mucopolysaccharidosis IIIA mice.
    Gustavsson S; Ohlin Sjöström E; Tjernberg A; Janson J; Westermark U; Andersson T; Makower Å; Arnelöf E; Andersson G; Svartengren J; Ekholm C; Svensson Gelius S
    Mol Genet Metab Rep; 2019 Dec; 21():100510. PubMed ID: 31528541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The laboratory diagnosis of mucopolysaccharidosis III (Sanfilippo syndrome): A changing landscape.
    Bodamer OA; Giugliani R; Wood T
    Mol Genet Metab; 2014; 113(1-2):34-41. PubMed ID: 25127543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sanfilippo syndrome: Overall review.
    Andrade F; Aldámiz-Echevarría L; Llarena M; Couce ML
    Pediatr Int; 2015 Jun; 57(3):331-8. PubMed ID: 25851924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Open field locomotor activity and anxiety-related behaviors in mucopolysaccharidosis type IIIA mice.
    Lau AA; Crawley AC; Hopwood JJ; Hemsley KM
    Behav Brain Res; 2008 Aug; 191(1):130-6. PubMed ID: 18453006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole Body and CNS Biodistribution of rhHNS in Cynomolgus Monkeys after Intrathecal Lumbar Administration: Treatment Implications for Patients with MPS IIIA.
    Chung JK; Pan L; Palmieri K; Youssef AS; McCauley TG
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case report of Sanfilippo syndrome - the long way to diagnosis.
    Lorenz D; Musacchio T; Kunstmann E; Grauer E; Pluta N; Stock A; Speer CP; Hebestreit H
    BMC Neurol; 2022 Mar; 22(1):93. PubMed ID: 35291973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early disease course is unaltered in mucopolysaccharidosis type IIIA (MPS IIIA) mice lacking α-synuclein.
    Soe K; Beard H; Neumann D; Trim PJ; Duplock S; Snel MF; Hopwood JJ; Hemsley KM
    Neuropathol Appl Neurobiol; 2019 Dec; 45(7):715-731. PubMed ID: 30907009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of molecular defects in Italian Sanfilippo A patients including 13 novel mutations.
    Di Natale P; Balzano N; Esposito S; Villani GR
    Hum Mutat; 1998; 11(4):313-20. PubMed ID: 9554748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of biomarkers for Sanfilippo syndrome.
    Saville JT; Flanigan KM; Truxal KV; McBride KL; Fuller M
    Mol Genet Metab; 2019; 128(1-2):68-74. PubMed ID: 31104888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Postnatal and prenatal diagnosis of mucopolysaccharidosis type III (Sanfilippo syndrome)].
    Zhang WM; Shi HP; Meng Y; Li BT; Qiu ZQ; Liu JT
    Zhonghua Er Ke Za Zhi; 2008 Jun; 46(6):407-10. PubMed ID: 19099774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sulfamidase deficiency in a family of Dachshunds: a canine model of mucopolysaccharidosis IIIA (Sanfilippo A).
    Fischer A; Carmichael KP; Munnell JF; Jhabvala P; Thompson JN; Matalon R; Jezyk PF; Wang P; Giger U
    Pediatr Res; 1998 Jul; 44(1):74-82. PubMed ID: 9667374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel mutations in Sanfilippo A syndrome: implications for enzyme function.
    Weber B; Guo XH; Wraith JE; Cooper A; Kleijer WJ; Bunge S; Hopwood JJ
    Hum Mol Genet; 1997 Sep; 6(9):1573-9. PubMed ID: 9285796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural History and Molecular Characteristics of Korean Patients with Mucopolysaccharidosis Type III.
    Kim MS; Yang A; Noh ES; Kim C; Bae GY; Lim HH; Park HD; Cho SY; Jin DK
    J Pers Med; 2022 Apr; 12(5):. PubMed ID: 35629088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioinformatics classification of mutations in patients with Mucopolysaccharidosis IIIA.
    Tanwar H; Kumar DT; Doss CGP; Zayed H
    Metab Brain Dis; 2019 Dec; 34(6):1577-1594. PubMed ID: 31385193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Uncommon Presentation of Mucopolysaccharidosis Type IIIb.
    Rezayi A; Feshangchi-Bonab M; Taherian R
    Iran J Child Neurol; 2019; 13(3):105-111. PubMed ID: 31327975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of 12 novel mutations in the alpha-N-acetylglucosaminidase gene in 14 patients with Sanfilippo syndrome type B (mucopolysaccharidosis type IIIB).
    Beesley CE; Young EP; Vellodi A; Winchester BG
    J Med Genet; 1998 Nov; 35(11):910-4. PubMed ID: 9832037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serial magnetic resonance imaging findings in mucopolysaccharidosis IIIB (Sanfilippo's syndrome B).
    Zafeiriou DI; Savvopoulou-Augoustidou PA; Sewell A; Papadopoulou F; Badouraki M; Vargiami E; Gombakis NP; Katzos GS
    Brain Dev; 2001 Oct; 23(6):385-9. PubMed ID: 11578848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sanfilippo syndrome in Turkey: Identification of novel mutations in subtypes A and B.
    Emre S; Terzioglu M; Tokatli A; Coskun T; Ozalp I; Weber B; Hopwood JJ
    Hum Mutat; 2002 Feb; 19(2):184-5. PubMed ID: 11793481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.